Budesonide, sold under the brand name Pulmicort among others, is a medication of the corticosteroid type. It is available as an inhaler, pill, nasal spray, and rectal forms. The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease
Anant Labs manufacture and furnish high quality Budesonide impurities for global markets. Our Budesonide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
budesonide51333-22-3PulmicortRhinocortEntocortPreferidRhinocort AquaEntocort ECUcerisPulmicort RespulesPulmicort FlexhalerBudenofalkBudesonidoBudesonidumPulmaxanRhinocort AllergyDTXSID8020202Pulmicort turbuhalerS-1320EOHILIAMAP-0010BudesonidaEltairQ3OKS62Q6XORTIKOSCHEBI:3207MAP0010R01AD05NSC-757788(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dioneDTXCID50820058UCERIS COMPONENT BUDESONIDEBREZTRI COMPONENT BUDESONIDEAIRSUPRA COMPONENT BUDESONIDE(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dionePregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-Tarpeyo(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-oneAircortBudecortButacortNasocortEntocort crDuoresp spiromaxBudeflam aquanaseBudelin novolizerPulmicort l.s.(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo(10.8.0.0^(2,9).0^(4,8).0^(13,18))icosa-14,17-dien-16-oneRhinocort aqua 64Budesonide InhalationRefChem:5621Budesonide Inhalation SuspensionA07EA06D07AC09R03BA02BUDESONIDE (ENTERIC COATED)257-139-7CortimentSpirocortBudesonCortiventMicronylRespulesBidienMFCD00083259Budesonide (Standard)MLS000028507(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehydeBudesonide MMXRhinocort alpha(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-oneSMR000058337Budecort InhalerBudesonidum [INN-Latin]Budesonido [INN-Spanish]InflammideBudiairMiflonideFvolirBudesonide [USAN:INN:BAN:JAN]Pulmaxan turbohalerPulmicort (TN)Pulmicort TopinasalRhinocort (TN)(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-oneBudesonide EasyhalerS 1320CCRIS 5230Entocort EC (TN)16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dioneSR-01000000101EINECS 257-139-7UNII-Q3OKS62Q6XJorvezaUltesaNoexGiona EasyhalerInflammide;Pulmicort;Rhinocort;Demotest;Entocort;Lisoflam;Prederid;Preferid;Pulmaxan;Budamax;Budeson;Nohalon;Budesonide CRSOlfex;Budesonide - IPNCGC00016862-01Budesonide; 16a,17-[(1RS)-butylidenebis(oxy)]-11ss,21-dihydroxypregna-1,4-diene-3,20-dionePregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11.beta.,16.alpha.)-Prestwick_840CAS-51333-22-3Uceris (TN)Budesonide (Mixture of Diastereomers)Budesonide, >=99%BUDESONIDE [MI]BUDESONIDE [INN]BUDESONIDE [JAN]Opera_ID_1696Prestwick0_000518Prestwick1_000518Prestwick2_000518Prestwick3_000518BUDESONIDE [USAN]BUDESONIDE [VANDF]Epitope ID:161750B 7777SCHEMBL4096BUDESONIDE [USP-RS]BUDESONIDE [WHO-DD]CHEMBL1370Lopac0_000174BSPBio_000475MLS001077323MLS002207112orb134514Budesonide (anti-inflammatory)SPBio_002396BPBio1_000523Budesonide (JP18/USP/INN)Budesonide - Bio-X trade markGTPL7434BUDESONIDE [ORANGE BOOK]HSDB 8279BUDESONIDE [EP MONOGRAPH]MSK2236BUDESONIDE [USP MONOGRAPH]HMS1569H17HMS2096H17HMS2232D17HMS3259H07HMS3260D09HMS3413B08HMS3413P17HMS3677B08HMS3677P17HMS3713H175-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-oneEohilia (budesonide oral suspension)Tox21_110653Tox21_201827Tox21_302815Tox21_500174BDBM50354850EBC-27074HY-13580RMSK2236-100ASYMBICORT COMPONENT BUDESONIDEBudesonide for system suitability CRSAKOS015969655MSK2236-1000AAC-4697CCG-204269CS-2063DB01222FB19346KS-1162LP00174NC00626NSC 757788SDCCGSBI-0050162.P002(+)-16alpha,17alpha-Butylidenedioxy-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dioneNCGC00021318-05NCGC00021318-06NCGC00021318-08NCGC00021318-18NCGC00089747-04NCGC00256415-01NCGC00259376-01NCGC00260859-01BB164267Budesonide 100 microg/mL in AcetonitrileCPD000058337FB173257HY-13580Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta,16-alpha)-Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dioneB3909B8112CS-0695032EU-0100174NS00000099Budesonide Solution in Acetonitrile, 100ug/mLD00246Budesonide Solution in Acetonitrile, 1000ug/mLEN300-19737584Q422212SR-01000000101-2SR-01000000101-6BRD-A34299591-001-03-4BRD-A34299591-001-22-4BRD-A34299591-001-25-7BRD-A34299591-001-26-5Budesonide Working Standard (Secondary Reference Standard)Budesonide, European Pharmacopoeia (EP) Reference StandardBudesonide, United States Pharmacopeia (USP) Reference StandardBudesonide, Pharmaceutical Secondary Standard; Certified Reference Material(11b,16a)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-Hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one
